Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-04

Clinical Trial Update: Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study [NA]

View source ↗

Summary

An ongoing hybrid Type 2 clinical trial evaluating an innovative treatment for Moral Injury Syndrome. It is currently enrolling by invitation at VA sites.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: VA Office of Research and Development | Conditions: Moral Injury Syndrome | NA | Status: ENROLLING_BY_INVITATION